Add Yahoo as a preferred source to see more of our stories on Google. Nearly 20 years ago, scientists stunned the world when they announced they had decoded the genes that make up a human being. As we ...

The development of new or worsening anemia did not decrease Jakafi’s efficacy in treating primary or secondary myelofibrosis. Patients with primary or secondary myelofibrosis who developed new or ...

Patients with myelofibrosis and anemia showed similar spleen size and symptom improvements as the overall JUMP study cohort when treated with ESAs or danazol and Jakafi. The JUMP trial, a phase 3b ...

A study published in the Journal of Medicinal Chemistry reports the discovery of a novel PHD inhibitor for the treatment of anemia. The academic breakthrough is powered by Chemistry42, InSilico ...

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal ...

Researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine pioneered a first of its kind gene therapy model that offers a potential ...

Please provide your email address to receive an email when new articles are posted on . Men with anemia were more likely to have correction of their condition with testosterone therapy vs. placebo.

Warm hemolytic anemia is a rare condition that affects your red blood cells. It causes anemia-like symptoms, such as fatigue, jaundice, and paleness. Share on Pinterest ZeynepKaya/Getty Images In warm ...

LONDON--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...

Researchers at Children's Hospital of Philadelphia have pioneered a new gene therapy model that offers a potential breakthrough in treating X-linked sideroblastic anemia (XLSA), a rare congenital ...